会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Method of using isomaltulose to suppress body fat accumulation
    • 使用异麦芽酮糖抑制体脂肪积累的方法
    • US09017745B2
    • 2015-04-28
    • US12832944
    • 2010-07-08
    • Jun KashimuraYukie NagaiTadashi Ebashi
    • Jun KashimuraYukie NagaiTadashi Ebashi
    • A23L1/29A23L1/236A21D2/18A23L1/307A23L2/60A61K31/70
    • A23L1/2363A21D2/181A23L2/60A23L27/33A23L33/20A23V2002/00A61K31/70A23V2250/62A23V2250/628A23V2250/606
    • A method for reducing body fat accumulation is provided that includes: providing a reducer of body fat accumulation, wherein the reducer comprises isomaltulose; having an individual ingest the reducer; and having the individual consume a carbohydrate having an α-1,6-glucosyl bond ratio of from 0% to less than 50% relative to the total bonds among constituent saccharides, wherein the reducer is ingested before or after or simultaneous with consuming the carbohydrate, and wherein the reducer reduces the individual's body fat accumulation caused by consuming the carbohydrate. The reducer of body fat accumulation includes isomaltulose (PALATINOSE™) as an active ingredient so that when the reducer is ingested and a carbohydrate having an α-1,6-glucosyl bond ratio of from 0% to less than 50% relative to the total bonds among constituent saccharides is consumed, accumulation of body fat resulting from ingesting the carbohydrate is reduced.
    • 提供一种降低体脂肪蓄积的方法,其包括:提供体脂肪蓄积的还原剂,其中所述还原剂包含异麦芽酮糖; 有个人摄入减速机; 并且使个体相对于构成糖之间的总键消耗具有0%至小于50%的α-1,6-葡糖基键比例的碳水化合物,其中所述还原剂在消耗碳水化合物之前或之后摄入 ,并且其中所述还原剂减少由消耗碳水化合物引起的个体的身体脂肪堆积。 身体脂肪蓄积的还原剂包括异麦芽酮糖(PALATINOSE TM)作为活性成分,使得当所述还原剂摄取时,具有0至小于50%的α-1,6-葡糖基键比的碳水化合物相对于总量 消耗组成糖之间的结合,减少摄取碳水化合物引起的身体脂肪积聚。
    • 6. 发明授权
    • Method of using isomaltulose to suppress blood glucose level increase
    • 使用异麦芽酮糖抑制血糖水平升高的方法
    • US09017744B2
    • 2015-04-28
    • US12832933
    • 2010-07-08
    • Jun KashimuraYukie NagaiTadashi Ebashi
    • Jun KashimuraYukie NagaiTadashi Ebashi
    • A23L1/29A23L1/236A21D2/18A23L1/307A23L2/60A61K31/70
    • A23L1/2363A21D2/181A23L2/60A23L27/33A23L33/20A23V2002/00A61K31/70A23V2250/62A23V2250/628A23V2250/606
    • A method for reducing blood glucose level increase is provided that includes: providing a reducer of blood glucose level increase, wherein the reducer comprises isomaltulose; having an individual ingest the reducer; and having the individual consume a carbohydrate having an α-1,6-glucosyl bond ratio of from 0% to less than 50% relative to the total bonds among constituent saccharides, wherein the reducer is ingested before or after or simultaneously with consuming the carbohydrate, and wherein the reducer reduces an increase in the individual's blood glucose level caused by consuming the carbohydrate. The reducer of blood glucose level increase includes isomaltulose (PALATINOSE™) as an active ingredient so that when the reducer is ingested and a carbohydrate having an α-1,6-glucosyl bond ratio of from 0% to less than 50% relative to the total bonds among constituent saccharides is consumed, an increase in blood glucose level caused by ingesting the carbohydrate is reduced.
    • 提供了降低血糖水平升高的方法,其包括:提供血糖水平升高的还原剂,其中所述还原剂包含异麦芽酮糖; 有个人摄入减速机; 并且使所述个体相对于构成糖中的总键消耗具有0%至小于50%的α-1,6-葡糖基键比例的碳水化合物,其中所述还原剂在消耗碳水化合物之前或之后或同时摄取 ,并且其中所述还原剂减少由消耗碳水化合物引起的个体血糖水平的增加。 血浆葡萄糖水平升高的还原剂包括异麦芽酮糖(PALATINOSE TM)作为活性成分,使得当所述还原剂摄取时,具有0至小于50%的α-1,6-葡糖基键比例的碳水化合物相对于 消耗组成糖中的总键,减少摄取碳水化合物引起的血糖水平升高。